InfuSystem Holdings, Inc. (INFU) is a publicly traded Healthcare sector company. As of May 21, 2026, INFU trades at $10.01 with a market cap of $179.62M and a P/E ratio of 26.47. INFU moved +5.38% today. Year to date, INFU is +15.19%; over the trailing twelve months it is +66.56%. Its 52-week range spans $4.61 to $11.04. Analyst consensus is strong buy with an average price target of $15.83. Rallies surfaces INFU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
InfuSystem Q1 EPS Beats at $0.05 While Revenue Drops 3% to $33.7M: InfuSystem Holdings reported Q1 2026 EPS of $0.05, surpassing estimates by one cent and swinging from a $0.01 loss a year earlier. Revenue fell 3% year-over-year to $33.68 million, with Device Solutions revenue down 17% offset partially by a 6% gain in Patient Services to $22.10 million.
| Metric | Value |
|---|---|
| Price | $10.01 |
| Market Cap | $179.62M |
| P/E Ratio | 26.47 |
| EPS | $0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.04 |
| 52-Week Low | $4.61 |
| Volume | 405 |
| Avg Volume | 0 |
| Revenue (TTM) | $142.40M |
| Net Income | $7.91M |
| Gross Margin | 56.75% |
3 analysts cover INFU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.83.